Skip to the card

2026-10-20 issue

Observed arrival · 2026-10-20

Residue’s evidence-graded peptide index

residue.info Visit website
Editorial interest 82/100 Selection signal · not a rating of the site

A searchable reference to 25 peptide monographs and comparisons, organized by evidence grade and linked to research and regulatory sources.

Landing page captured for the 2026-10-20 issue.
For
Readers checking peptide research against primary sources
Worth noticing
The index separates PubMed record volume from evidence grade and lists registered studies, including active-study counts.

Field notes

The index can be filtered by evidence grade or peptide class and sorted by grade, PubMed-record count, registered-study count, or name. Its displayed counts distinguish registered studies from those marked active, and the page cautions that a larger literature does not by itself mean stronger evidence. A featured comparison reports trial results for semaglutide and tirzepatide alongside links to the cited studies.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Cicada Prime

344,979 arrived 1,000 judged 983 catalogued Enter the complete issue
residue.info

Landing page observed 2026-10-20. The live site may have changed.